PARIET, ENTERIC-COATED TABLET 20MG
JANSSEN INC
View this drug's full profile page →
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is there a shortage of PARIET, ENTERIC-COATED TABLET 20MG in Canada?
Yes. PARIET, ENTERIC-COATED TABLET 20MG has an active shortage reported to Health Canada (last updated September 23, 2026).
Why is PARIET, ENTERIC-COATED TABLET 20MG not available?
The reason the manufacturer reported: Demand increase for the drug.
When will PARIET, ENTERIC-COATED TABLET 20MG be available again?
The manufacturer's estimated resolution date is October 24, 2026. This is an estimate and can change; follow this page to get an email when the status changes.
Proton Pump Inhibitor (PPI) Shortage in Canada: Omeprazole, Pantoprazole, Rabeprazole
Why a shortage of one PPI brand rarely means the whole class is unavailable, when a pharmacist can swap manufacturers, and when it needs your prescriber.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Closest Matches
RABEPRAZOLE EC
MELIAPHARM INC
TARO-RABEPRAZOLE
SUN PHARMA CANADA INC
DOM-RABEPRAZOLE EC
DOMINION PHARMACAL
Other Products
ABBOTT-RABEPRAZOLE
BGP PHARMA ULC
NTP-RABEPRAZOLE EC
NT PHARMA CANADA LTD
PARIET, ENTERIC-COATED TABLET 10MG
JANSSEN INC
What this means
Does this mean my pharmacy is out of stock?
Not necessarily — a national shortage doesn't mean every pharmacy has run out. Some locations may still have stock, especially of a specific strength or pack size.
What should I do?
Contact your pharmacy before your current supply runs low, and ask your pharmacist about next steps if they're out.
Estimated Resolution
2026-10-24
~26 days remaining (estimate)
This is the manufacturer's estimated date, not a guarantee — actual resolution may come earlier or later.
DIN
02243797
Strength
20MG
Dosage Form
TABLET (ENTERIC-COATED)
Route
ORAL
Active Ingredient
RABEPRAZOLE SODIUM
Tier
Unrated
Last Updated
2026-09-23
Reason for Shortage
Demand increase for the drug.
Other Products from JANSSEN INC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
DIN 02538555
DIN 02538563
5MG · DIN 02493233
3MG · DIN 02493217
4MG · DIN 02493225
0.5MG · DIN 02397447
1.5MG · DIN 02397455
18MG · DIN 02247732
54MG · DIN 02247734
36MG · DIN 02247733
27MG · DIN 02250241
100MG · DIN 02455951